25‐Hydroxyvitamin D Levels and Markers of Subclinical Myocardial Damage and Wall Stress: The Atherosclerosis Risk in Communities Study by Erin D. Michos,

Slides:

Advertisements

Similar presentations

Hazard of incident coronary heart disease by diabetes status, with or without elevation of troponin T No diabetes Pre- diabetes Diabetes No diabetes Pre-

Advertisements

Cystatin C– and Creatinine-Based Estimated Glomerular Filtration Rate, Vascular Disease, and Mortality in Persons With Diabetes in the U.S. Featured Article:

PEACE BNP: Omland, T. et al. J Am Coll Cardiol 2007; 50:205–14 Copyright ©2007 American College of Cardiology Foundation. Restrictions may apply. Prognostic.

Journal Club Recalibration of Blood Analytes over 25 Years in the Atherosclerosis Risk in Communities Study: Impact of Recalibration on Chronic Kidney.

Kimberly Dunbar, PA-S2 Follow-up of Cardiovascular Risk Markers in Hypertensive Patients Treated with Irbesartan: Results of the i-SEARCH Plus Registry.

Baseline Characteristics of 987 Individuals With Stable Coronary Heart Disease by Amino Terminal Fragment of the Prohormone Brain-Type Natriuretic Peptide.

Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Effect of Serelaxin on Cardiac, Renal, and Hepatic.

Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Effect of Serelaxin on Cardiac, Renal, and Hepatic.

Date of download: 6/10/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effects of Homocysteine-Lowering With Folic Acid.

Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Next Steps in Primary Prevention of Coronary Heart.

The LIVES Sub-analysis

Volume 385, Issue 9985, Pages (June 2015)

All-cause mortality by treatment group

Alcohol Consumption and Cardiac Biomarkers: The Atherosclerosis Risk in Communities (ARIC) Study M. Lazo, Y. Chen, J.W. McEvoy, C. Ndumele, S. Konety,

From: Clinical Outcomes of Metformin Use in Populations With Chronic Kidney Disease, Congestive Heart Failure, or Chronic Liver DiseaseA Systematic Review.

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Copyright © 2015 by the American Osteopathic Association.

by Qi Sun, Monik C. Jiménez, Mary K. Townsend, Eric B. Rimm, JoAnn E

Serum Total 25‐OH Vitamin D Adds Little Prognostic Value in Patients Undergoing Coronary Catheterization by Michael E. Gerling, Matthew T. James, Stephen.

by Thomas H. Marwick, and Markus Schwaiger Circ Cardiovasc Imaging

Associations of renal impairment (adjusted odds ratio and 95% CI) and the presence of individual small vessel disease markers stratified by age. Associations.

Resistant Hypertension, Time‐Updated Blood Pressure Values and Renal Outcome in Type 2 Diabetes Mellitus by Francesca Viazzi, Pamela Piscitelli, Antonio.

Prediction of Atrial Fibrillation in a Racially Diverse Cohort: The Multi‐Ethnic Study of Atherosclerosis (MESA)‏ by Alvaro Alonso, Nicholas S. Roetker,

Prevalence of Intracranial Atherosclerotic Stenosis Using High-Resolution Magnetic Resonance Angiography in the General Population by Muhammad Fareed K.

Dietary Phosphorus, Blood Pressure, and Incidence of Hypertension in the Atherosclerosis Risk in Communities Study and the Multi-Ethnic Study of Atherosclerosis.

Persistent High Serum Bicarbonate and the Risk of Heart Failure in Patients With Chronic Kidney Disease (CKD): A Report From the Chronic Renal Insufficiency.

Excessively High Hydration Volume May Not Be Associated With Decreased Risk of Contrast‐Induced Acute Kidney Injury After Percutaneous Coronary Intervention.

C‐Reactive Protein Identifies Low‐Risk Metabolically Healthy Obese Persons: The European Prospective Investigation of Cancer–Norfolk Prospective Population.

Risk Factors for Rehospitalization for Acute Coronary Syndromes and Unplanned Revascularization Following Acute Myocardial Infarction by Suzanne V. Arnold,

Protocol‐Driven Allied Health Post‐Discharge Transition Clinic to Reduce Hospital Readmissions in Heart Failure by Erin K. Donaho, Andrea C. Hall, Jennifer.

Prospective associations of plasma phospholipid trans/trans-18:2 with total mortality, CVD and CHD before and after mutual adjustment without correction.

Risk of Heart Failure Among Postmenopausal WomenCLINICAL PERSPECTIVE

by John T. Wilkins, Hongyan Ning, Neil J. Stone, Michael H

Chapter 2: Pharmacological cholesterol-lowering treatment in adults

Shoshana H. Ballew, PhD, Yan Chen, BS, Natalie R. Daya, MPH, Job G

Cardiovascular Disease and CKD: Core Curriculum 2010

FIGURE 1 Study subjects. KNHANES, Korean NHANES; 25(OH)D3, 25-hydroxyvitamin D3. From: Severe vitamin D deficiency is a risk factor for renal hyperfiltration.

Description of studies for pooled analyses

American Heart Association's Life's Simple 7: Avoiding Heart Failure and Preserving Cardiac Structure and Function Aaron R. Folsom, MD, Amil M. Shah,

Lifetime Risk of Venous Thromboembolism in Two Cohort Studies

David J.A. Jenkins et al. JACC 2018;71:

Volume 93, Issue 1, Pages (January 2018)

Baseline Characteristics of the Study Cohort*

Baseline Characteristics

Volume 76, Issue 6, Pages (September 2009)

Treatment Algorithm for Guideline-Directed Medical Therapy Including Novel Therapies (2,9) Green diamonds indicate Class I guideline recommendations, while.

The Research Question Heart failure (HF) and atrial fibrillation (AF) frequently coexist and are associated with many adverse outcomes HF and AF share.

(A) 1-year mortality in relation to estimated glomerular filtration rate (eGFR), age (n=47 636) and presence of diabetes mellitus (n=47 624). (A) 1-year.

Baseline Characteristics

Glycated Hemoglobin Levels (A1C)

Methods for guideline development

Volume 85, Issue 5, Pages (May 2014)

Enrollment of patients.

Relative risk of a major coronary heart disease event (myocardial infarction incidence, fatal coronary heart disease, or coronary revascularization) for.

(A) Mortality in patients with heart failure and different estimated glomerular filtration rate (eGFR) strata, crude survival assessed by Kaplan-Meier.

Serum 25(OH)D levels stratified by the presence or absence of nephropathy. Serum 25(OH)D levels stratified by the presence or absence of nephropathy. The.

Sotirios Tsimikas JACC 2017;69:

Stress and coronary heart diseases

Baseline characteristics of the 1,842 men without coronary heart disease and the 230 men with a first coronary heart disease event during the 13-year.

Baseline demographics and clinical characteristics of 3,956 rosuvastatin-treated patients Donald G. Vidt, et al. Am J Cardiol 2006;97:1602–1606.

Occupational Life Expectancy in England & Wales,

Shoshana H. Ballew, PhD, Yan Chen, BS, Natalie R. Daya, MPH, Job G

Ann M. O'Hare, MA, MD American Journal of Kidney Diseases

Increase of physical activity over time associated with lower HF risk

Risk differences for incident stroke, coronary heart disease (CHD), and cardiovascular mortality (per 1000 person-years) by clinical risk factor in the.

Risk for cardiovascular disease and all-cause death according to RHR: (A) as categorical variable (HR≥75 bpm vs HR

Associations of peripartum biomarker levels with e' at 1 month postpartum (PP2). Associations of peripartum biomarker levels with e' at 1 month postpartum.

Left Ventricular Mass at MRI and Long-Term Risk of Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis (MESA) Left ventricular hypertrophy.

Glucose-lowering medication in type 2 diabetes: overall approach.

Association Between Hypertension and Kidney Function Decline: The Atherosclerosis Risk in Communities (ARIC) Study Zhi Yu, Casey M. Rebholz, Eugenia.

Presentation transcript:

25‐Hydroxyvitamin D Levels and Markers of Subclinical Myocardial Damage and Wall Stress: The Atherosclerosis Risk in Communities Study by Erin D. Michos, Elizabeth Selvin, Jeffrey R. Misialek, John W. McEvoy, Chiadi E. Ndumele, Aaron R. Folsom, Christie M. Ballantyne, and Pamela L. Lutsey J Am Heart Assoc Volume 5(11):e003575 November 7, 2016 © 2016 Erin D. Michos et al.

Inclusion and exclusion criteria for participants for cross‐sectional analyses at ARIC visit 2 (1990–1992). 25(OH)D indicates 25‐hydroxyvitamin D; ARIC, Atherosclerosis Risk in Communities; CHD, coronary heart disease; eGFR, estimated glomerular f... Inclusion and exclusion criteria for participants for cross‐sectional analyses at ARIC visit 2 (1990–1992). 25(OH)D indicates 25‐hydroxyvitamin D; ARIC, Atherosclerosis Risk in Communities; CHD, coronary heart disease; eGFR, estimated glomerular filtration rate; HF, heart failure; NT‐proBNP, N‐terminal pro–brain natriuretic peptide. Erin D. Michos et al. J Am Heart Assoc 2016;5:e003575 © 2016 Erin D. Michos et al.

Inclusion and exclusion criteria for participants for prospective analyses from Atherosclerosis Risk in Communities visit 2 (1990–1992) to visit 4 (1996–1998). Inclusion and exclusion criteria for participants for prospective analyses from Atherosclerosis Risk in Communities visit 2 (1990–1992) to visit 4 (1996–1998). NT‐proBNP indicates N‐terminal pro–brain natriuretic peptide. Erin D. Michos et al. J Am Heart Assoc 2016;5:e003575 © 2016 Erin D. Michos et al.